{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:16:59Z","timestamp":1792300619589,"version":"4.4.0"},"reference-count":181,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"am","delay-in-days":328,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017125","name":"Coll\u00e8ge National des Gyn\u00e9cologues et Obst\u00e9triciens Fran\u00e7ais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017125","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ejogrb.2023.07.001","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T04:56:25Z","timestamp":1689569785000},"page":"90-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Management of women with abnormal uterine bleeding: Clinical practice guidelines of the French National College of Gynaecologists and Obstetricians (CNGOF)"],"prefix":"10.1016","volume":"288","author":[{"given":"J.L.","family":"Brun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Plu-Bureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Huchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Ah-Kit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Barral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Chauvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Cornelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cortet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Crochet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Delporte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Dubernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Giraudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gosset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Graesslin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hugon-Rodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Lecointre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Legendre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Maitrot-Mantelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Marcellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Miquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Le Mitouard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Proust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Roquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Rousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Sangnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sapoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Thubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Tr\u00e9molli\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Vernhet-Kovacsik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Marret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejogrb.2010.07.016","article-title":"Clinical practice guidelines on menorrhagia: Management of abnormal uterine bleeding before menopause","volume":"152","author":"Marret","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0010","unstructured":"National Institute for Health and Care Excellence (NICE). Heavy menstrual bleeding: Assessment and management. NICE guideline [NG88]. 2018."},{"key":"10.1016\/j.ejogrb.2023.07.001_b0015","doi-asserted-by":"crossref","unstructured":"Screening and Management of Bleeding Disorders in Adolescents with Heavy Menstrual Bleeding: ACOG COMMITTEE OPINION, Number 785. Obstet Gynecol. 2019;134:E71\u201383.","DOI":"10.1097\/AOG.0000000000003411"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0020","first-page":"3","article-title":"CNGOF Guidelines for Clinical Practice: Revision of the Methodology","volume":"48","author":"Schmitz","year":"2020","journal-title":"Gynecol Obstet Fertil Senol"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jclinepi.2015.11.017","article-title":"A guide for health professionals to interpret and use recommendations in guidelines developed with the GRADE approach","volume":"72","author":"Neumann","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2011.01.001","article-title":"The FIGO classification of causes of abnormal uterine bleeding","volume":"113","author":"Munro","year":"2011","journal-title":"Int J Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0035","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jmig.2019.11.013","article-title":"Classification and reporting systems for adenomyosis","volume":"27","author":"Munro","year":"2020","journal-title":"J Minim Invasive Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.07.001_b0040","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ijgo.12666","article-title":"The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions","volume":"143","author":"Munro","year":"2018","journal-title":"Int J Gynecol Obstet"},{"issue":"8","key":"10.1016\/j.ejogrb.2023.07.001_b0045","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.1990.tb16249.x","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0050","article-title":"Pictorial methods to assess heavy menstrual bleeding in research and clinical practice: A systematic literature review","volume":"20","author":"Magnay","year":"2020","journal-title":"BMC Womens Health [Internet]"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.07.001_b0055","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/08880018.2012.699165","article-title":"Quantifying the PBAC in a pediatric and adolescent gynecology population","volume":"29","author":"Sanchez","year":"2012","journal-title":"Pediatr Hematol Oncol"},{"issue":"12","key":"10.1016\/j.ejogrb.2023.07.001_b0060","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/jama.1997.03540360041028","article-title":"Prevalence of iron deficiency in the United States","volume":"277","author":"Looker","year":"1997","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/uog.6259","article-title":"Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20\u201374 years","volume":"33","author":"Dreisler","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"31","key":"10.1016\/j.ejogrb.2023.07.001_b0070","article-title":"Prevalence of abnormal uterine bleeding according to new International Federation of Gynecology and Obstetrics classification in Chinese women of reproductive age: A cross-sectional study","volume":"97","author":"Sun","year":"2018","journal-title":"Med U S [Internet]"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.07.001_b0075","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/uog.8900","article-title":"Adenomyosis: Three-dimensional sonographic findings of the junctional zone and correlation with histology","volume":"37","author":"Exacoustos","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0080","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1469-0705.2001.00430.x","article-title":"Transvaginal sonography combined with saline contrast sonohysterography in evaluating the uterine cavity in premenopausal patients with abnormal uterine bleeding","volume":"18","author":"Dueholm","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0085","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0015-0282(01)01900-8","article-title":"Evaluation of the uterine cavity with magnetic resonance imaging, transvaginal sonography, hysterosonographic examination, and diagnostic hysteroscopy","volume":"76","author":"Dueholm","year":"2001","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.07.001_b0090","doi-asserted-by":"crossref","first-page":"537.e1","DOI":"10.1016\/j.ajog.2008.12.037","article-title":"Magnetic resonance imaging and transvaginal ultrasound for determining fibroid burden: implications for research and clinical care","volume":"200","author":"Levens","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.07.001_b0095","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/jog.12994","article-title":"Three-dimensional saline-infusion sonohysterography is useful for the identification of endometrial polyp","volume":"42","author":"Inoue","year":"2016","journal-title":"J Obstet Gynaecol Res"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.07.001_b0100","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2214\/AJR.05.1476","article-title":"Comparison of MRI and sonography in the preliminary evaluation for fibroid embolization","volume":"187","author":"Spielmann","year":"2006","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0105","doi-asserted-by":"crossref","unstructured":"Tellum T, Nygaard S, Lieng M. Noninvasive diagnosis of adenomyosis: a structured review and meta-analysis of diagnostic accuracy in imaging. J Minim Invasive Gynecol. 2020;27(2):408-418.e3.","DOI":"10.1016\/j.jmig.2019.11.001"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0110","doi-asserted-by":"crossref","unstructured":"Sam M, Raubenheimer M, Manolea F, Aguilar H, Mathew RP, Patel VH, et al. Accuracy of findings in the diagnosis of uterine adenomyosis on ultrasound. Abdom Radiol. 2020;45(3):842\u201350.","DOI":"10.1007\/s00261-019-02231-9"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0115","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/uog.17352","article-title":"Accuracy of saline contrast sonohysterography in detection of endometrial polyps and submucosal leiomyomas in women of reproductive age with abnormal uterine bleeding: systematic review and meta-analysis","volume":"50","author":"Bittencourt","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0120","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00404-016-4043-8","article-title":"Could body mass index be an indicator for endometrial biopsy in premenopausal women with heavy menstrual bleeding?","volume":"294","author":"Guraslan","year":"2016","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0125","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejogrb.2009.09.023","article-title":"Premenopausal bleeding: When should the endometrium be investigated?-A retrospective non-comparative study of 3006 women","volume":"148","author":"Iram","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0130","doi-asserted-by":"crossref","unstructured":"Wise MR, Gill P, Lensen S, Thompson JMD, Farquhar CM. Body mass index trumps age in decision for endometrialbiopsy: cohort study of symptomatic premenopausal women. Am J Obstet Gynecol. 2016;215(5):598.e1-598.e8.","DOI":"10.1016\/j.ajog.2016.06.006"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.07.001_b0135","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1034\/j.1600-0412.2003.00191.x","article-title":"A systematic review of transvaginal ultrasonography, sonohysterography and hysteroscopy for the investigation of abnormal uterine bleeding in premenopausal women","volume":"82","author":"Farquhar","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.07.001_b0140","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1148\/radiology.191.3.8184058","article-title":"Endometrial polyps, hyperplasia, and carcinoma in postmenopausal women: Differentiation with endovaginal sonography","volume":"191","author":"Hulka","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0145","doi-asserted-by":"crossref","unstructured":"Thorneycroft IH. Cycle control with oral contraceptives: A review of the literature. Am J Obstet Gynecol. 1999;180(2 II):S280\u20137.","DOI":"10.1016\/S0002-9378(99)70719-2"},{"issue":"SUPPL. 1","key":"10.1016\/j.ejogrb.2023.07.001_b0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13625180801959931","article-title":"The effects of Implanon\u00ae on menstrual bleeding patterns","volume":"13","author":"Mansour","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.contraception.2011.01.002","article-title":"Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy","volume":"84","author":"Wiegratz","year":"2011","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.07.001_b0160","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ajog.2016.12.008","article-title":"Unscheduled vaginal bleeding with progestin-only contraceptive use","volume":"216","author":"Zigler","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.ejogrb.2023.07.001_b0165","first-page":"717","article-title":"The management of irregular bleeding in women using contraception","volume":"46","author":"Foran","year":"2017","journal-title":"Aust Fam Physician"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0170","unstructured":"CDC. Appendix E. US SPR. Reproductive health [Internet]. 2019."},{"key":"10.1016\/j.ejogrb.2023.07.001_b0175","doi-asserted-by":"crossref","unstructured":"Abdel-Aleem H, D\u2019Arcangues C, Vogelsong KM, G\u00fclmezoglu AM. Treatment of vaginal bleeding irregularities induced by progestin only contraceptives. Cochrane Database Syst Rev [Internet]. 2007;(4).","DOI":"10.1002\/14651858.CD003449.pub2"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.07.001_b0180","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jpag.2013.06.003","article-title":"Prevalence of Hemostatic Disorders in Adolescents with Abnormal Uterine Bleeding","volume":"26","author":"Seravalli","year":"2013","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.07.001_b0185","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1067\/mpd.2001.113042","article-title":"Bleeding disorders: A common cause of menorrhagia in adolescents","volume":"138","author":"Bevan","year":"2001","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0190","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s004040100192","article-title":"Hematological abnormalities in adolescent menorrhagia","volume":"266","author":"Oral","year":"2002","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.AOG.0000148889.15061.fb","article-title":"Age and the prevalence of bleeding disorders in women with menorrhagia","volume":"105","author":"Philipp","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.07.001_b0200","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1479-828X.2005.00470.x","article-title":"Bleeding disorders in teenagers presenting with menorrhagia","volume":"45","author":"Jayasinghe","year":"2005","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.07.001_b0205","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2516.2007.01496.x","article-title":"The prevalence of disorders of haemostasis in adolescents with menorrhagia referred to a haemophilia treatment centre","volume":"13","author":"Mikhail","year":"2007","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0210","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/hae.12012","article-title":"Menstrual bleeding patterns and prevalence of bleeding disorders in a multidisciplinary adolescent haematology clinic","volume":"19","author":"Vo","year":"2013","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0215","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1111\/hae.12091","article-title":"Bleeding disorders in adolescents with menorrhagia: An institutional experience","volume":"19","author":"Rodriguez","year":"2013","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0220","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jpag.2018.11.005","article-title":"Bleeding disorders in adolescents with heavy menstrual bleeding: The Queensland Statewide Paediatric and Adolescent Gynaecology Service","volume":"32","author":"O\u2019Brien","year":"2019","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0225","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jpag.2016.09.012","article-title":"The utility of routine ultrasound in the diagnosis and management of adolescents with abnormal uterine bleeding","volume":"30","author":"Pecchioli","year":"2017","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0230","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.fertnstert.2015.04.042","article-title":"Uterine volume and endometrial thickness in healthy girls evaluated by ultrasound (3-dimensional) and magnetic resonance imaging","volume":"104","author":"Hagen","year":"2015","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.07.001_b0235","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1083-3188(98)70138-X","article-title":"Tenoxicam versus lynestrenol-ethinyl estradiol treatment of dysfunctional uterine bleeding cases during adolescence","volume":"11","author":"Creatsas","year":"1998","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.07.001_b0240","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3109\/01443615.2010.484107","article-title":"Effectiveness and tolerability of levonorgestrel intrauterine system in adolescents","volume":"30","author":"Aslam","year":"2010","journal-title":"J Obstet Gynaecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.07.001_b0245","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.contraception.2003.11.008","article-title":"Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: A comparative study","volume":"69","author":"Suhonen","year":"2004","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.07.001_b0250","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jpag.2018.02.130","article-title":"Treatment modalities in adolescents who present with heavy menstrual bleeding","volume":"31","author":"Alaqzam","year":"2018","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"8","key":"10.1016\/j.ejogrb.2023.07.001_b0255","article-title":"Cyclical progestogens for heavy menstrual bleeding","volume":"2019","author":"Bofill Rodriguez","year":"2019","journal-title":"Cochrane Database Syst Rev [Internet]"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.07.001_b0260","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/01443610600913932","article-title":"Role of tranexamic acid in management of dysfunctional uterine bleeding in comparison with medroxyprogesterone acetate","volume":"26","author":"Kriplani","year":"2006","journal-title":"J Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.07.001_b0265","article-title":"Antifibrinolytics for heavy menstrual bleeding","volume":"2018","author":"Bryant-Smith","year":"2018","journal-title":"Cochrane Database Syst Rev [Internet]"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.07.001_b0270","article-title":"Progestogen-releasing intrauterine systems for heavy menstrual bleeding","volume":"2020","author":"Bofill Rodriguez","year":"2020","journal-title":"Cochrane Database Syst Rev [Internet]"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0275","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1471-0528.2008.01926.x","article-title":"The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: A case-control study using the General Practice Research Database","volume":"116","author":"Sundstr\u00f6m","year":"2009","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"9190","key":"10.1016\/j.ejogrb.2023.07.001_b0280","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0140-6736(99)03132-3","article-title":"Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications","volume":"354","author":"Poulter","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.07.001_b0285","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: A systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.07.001_b0290","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.contraception.2004.07.009","article-title":"Progestogen-only contraception in women at high risk of venous thromboembolism","volume":"70","author":"Conard","year":"2004","journal-title":"Contraception"},{"issue":"12","key":"10.1016\/j.ejogrb.2023.07.001_b0295","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/j.1471-0528.1997.tb11004.x","article-title":"A randomised comparison of medical and hysteroscopic management in women consulting a gynaecologist for treatment of heavy menstrual loss","volume":"104","author":"Cooper","year":"1997","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.07.001_b0300","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1471-0528.1999.tb08240.x","article-title":"Two-year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: Clinical and quality of life outcomes","volume":"106","author":"Cooper","year":"1999","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"12","key":"10.1016\/j.ejogrb.2023.07.001_b0305","first-page":"1222","article-title":"Five-year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: Clinical and quality of life outcomes","volume":"108","author":"Cooper","year":"2001","journal-title":"Br J Obstet Gynaecol"},{"issue":"12","key":"10.1016\/j.ejogrb.2023.07.001_b0310","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/jama.291.12.1447","article-title":"Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: The Medicine or Surgery (Ms) Randomized Trial","volume":"291","author":"Kuppermann","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0315","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ajog.2005.08.014","article-title":"Randomized trial of medical treatment versus hysterectomy for abnormal uterine bleeding: Resource use in the Medicine or Surgery (Ms) trial","volume":"194","author":"Showstack","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0320","doi-asserted-by":"crossref","unstructured":"Bergeron C, Laberge PY, Boutin A, Th\u00e9riault MA, Valcourt F, Lemyre M, et al. Endometrial ablation or resection versus levonorgestrel intra-uterine system for the treatment of women with heavy menstrual bleeding and a normal uterine cavity: A systematic review with meta-analysis. Hum Reprod Update. 2020;26(2):302\u201311.","DOI":"10.1093\/humupd\/dmz051"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0325","first-page":"CD001501","article-title":"Endometrial resection and ablation techniques for heavy menstrual bleeding","volume":"1","author":"Bofill Rodriguez","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0330","doi-asserted-by":"crossref","unstructured":"de L\u00e9otoing L, Chaize G, Fernandes J, Toth D, Descamps P, Dubernard G, et al. The surgical treatment of idiopathic abnormal uterine bleeding: An analysis of 88 000 patients from the French exhaustive national hospital discharge database from 2009 to 2015. PLoS ONE [Internet]. 2019;14(6).","DOI":"10.1371\/journal.pone.0217579"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0335","article-title":"Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding","volume":"2021","author":"Bofill Rodriguez","year":"2021","journal-title":"Cochrane Database Syst Rev [Internet]"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0340","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0002-9378(97)70445-9","article-title":"Endometrial resection versus vaginal hysterectomy for menorrhagia: Long- term clinical and quality-of-life outcomes","volume":"177","author":"Crosignani","year":"1997","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0345","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1067\/mob.2003.60","article-title":"Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: A prospective randomized trial","volume":"188","author":"Zupi","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.07.001_b0350","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/01.AOG.0000292083.97478.38","article-title":"Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding: A randomized controlled trial","volume":"110","author":"Dickersin","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.ejogrb.2023.07.001_b0355","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/j.1447-0756.2011.01596.x","article-title":"Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study","volume":"37","author":"Sesti","year":"2011","journal-title":"J Obstet Gynaecol Res"},{"issue":"10207","key":"10.1016\/j.ejogrb.2023.07.001_b0360","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(19)31790-8","article-title":"Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial","volume":"394","author":"Cooper","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0365","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1471-0528.1996.tb09666.x","article-title":"Randomised trial comparing hysterectomy and transcervical endometrial resection: Effect on health related quality of life and costs two years after surgery","volume":"103","author":"Sculpher","year":"1996","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"6814","key":"10.1016\/j.ejogrb.2023.07.001_b0370","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1136\/bmj.303.6814.1362","article-title":"A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia","volume":"303","author":"Gannon","year":"1991","journal-title":"Br Med J"},{"issue":"10","key":"10.1016\/j.ejogrb.2023.07.001_b0375","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jgyn.2015.09.027","article-title":"Hysterectomy for benign pathology: Guidelines for clinical practice","volume":"44","author":"Deffieux","year":"2015","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"11","key":"10.1016\/j.ejogrb.2023.07.001_b0380","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/bjs.9861","article-title":"Meta-analysis of the association between preoperative anaemia and mortality after surgery","volume":"102","author":"Fowler","year":"2015","journal-title":"Br J Surg"},{"issue":"9800","key":"10.1016\/j.ejogrb.2023.07.001_b0385","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0140-6736(11)61381-0","article-title":"Preoperative anaemia and postoperative outcomes in non-cardiac surgery: A retrospective cohort study","volume":"378","author":"Musallam","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0390","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/aogs.13718","article-title":"The effect of anemia severity on postoperative morbidity among patients undergoing laparoscopic hysterectomy for benign indications","volume":"99","author":"Tyan","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0395","doi-asserted-by":"crossref","unstructured":"Murji A, Lam M, Allen B, Richard L, Shariff SZ, Austin PC, et al. Risks of preoperative anemia in women undergoing elective hysterectomy and myomectomy. Am J Obstet Gynecol. 2019;221(6):629.e1-629.e18.","DOI":"10.1016\/j.ajog.2019.07.018"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0400","doi-asserted-by":"crossref","unstructured":"Richards T, Musallam KM, Nassif J, Ghazeeri G, Seoud M, Gurusamy KS, et al. Impact of preoperative anaemia and blood transfusion on postoperative outcomes in gynaecological surgery. PLoS ONE [Internet]. 2015;10(7).","DOI":"10.1371\/journal.pone.0130861"},{"issue":"11","key":"10.1016\/j.ejogrb.2023.07.001_b0405","article-title":"Preoperative medical therapy before surgery for uterine fibroids","volume":"2017","author":"Lethaby","year":"2017","journal-title":"Cochrane Database Syst Rev [Internet]"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0410","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jmig.2019.03.021","article-title":"Effect of Perioperative Transfusion on Postoperative Morbidity Following Minimally Invasive Hysterectomy for Benign Indications","volume":"27","author":"Tyan","year":"2020","journal-title":"J Minim Invasive Gynecol"},{"issue":"12","key":"10.1016\/j.ejogrb.2023.07.001_b0415","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009218","article-title":"Intermittent iron supplementation for reducing anaemia and its associated impairments in menstruating women","volume":"2011","author":"Fern\u00e1ndez-Gaxiola","year":"2011","journal-title":"Cochrane Database Syst Rev [Internet]"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.07.001_b0420","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011588","article-title":"Iron therapy for pre-operative anaemia","volume":"2015","author":"Ng","year":"2015","journal-title":"Cochrane Database Syst Rev [Internet]"},{"issue":"10259","key":"10.1016\/j.ejogrb.2023.07.001_b0425","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(20)31539-7","article-title":"Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial","volume":"396","author":"Richards","year":"2020","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ejogrb.2023.07.001_b0430","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jama.2019.0554","article-title":"Patient Blood Management: Recommendations from the 2018 Frankfurt Consensus Conference","volume":"321","author":"Mueller","year":"2019","journal-title":"JAMA - J Am Med Assoc"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0435","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia. A long-term study of \u201cuntreated\u201d hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.07.001_b0440","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ajog.2015.03.037","article-title":"Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: A systematic review and metaanalysis of randomized trials","volume":"213","author":"Abu Hashim","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.ejogrb.2023.07.001_b0445","article-title":"Levonorgestrel-releasing intrauterine system for endometrial hyperplasia","volume":"2020","author":"Mittermeier","year":"2020","journal-title":"Cochrane Database Syst Rev [Internet]"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.07.001_b0450","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/1933719115623643","article-title":"Depo-provera versus norethisterone acetate in management of endometrial hyperplasia without atypia","volume":"23","author":"Nooh","year":"2016","journal-title":"Reprod Sci"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.07.001_b0455","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s12325-017-0509-8","article-title":"Comparing the administration of letrozole and megestrol acetate in the treatment of women with simple endometrial hyperplasia without atypia: A randomized clinical trial","volume":"34","author":"Moradan","year":"2017","journal-title":"Adv Ther"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.07.001_b0460","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000341708","article-title":"A prospective study of rollerball endometrial ablation in the management of refractory recurrent symptomatic endometrial hyperplasia without atypia","volume":"74","author":"Avci","year":"2012","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0465","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00404-014-3417-z","article-title":"Efficacies and pregnant outcomes of fertility-sparing treatment with medroxyprogesterone acetate for endometrioid adenocarcinoma and complex atypical hyperplasia: our experience and a review of the literature","volume":"291","author":"Ohyagi-Hara","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0470","doi-asserted-by":"crossref","unstructured":"Gallos ID, Yap J, Rajkhowa M, Luesley DM, Coomarasamy A, Gupta JK. Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: A systematic review and metaanalysis. Am J Obstet Gynecol. 2012;207(4):266.e1-266.e12.","DOI":"10.1016\/j.ajog.2012.08.011"},{"issue":"11","key":"10.1016\/j.ejogrb.2023.07.001_b0475","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1093\/humrep\/det320","article-title":"LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: A long-term comparative cohort study","volume":"28","author":"Gallos","year":"2013","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0480","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma: A systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0485","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/IGC.0b013e31819960ba","article-title":"Pregnancy outcomes using assisted reproductive technology after fertility-preserving therapy in patients with endometrial adenocarcinoma or atypical complex hyperplasia","volume":"19","author":"Han","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.07.001_b0490","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0029-7844(97)00297-4","article-title":"Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40","volume":"90","author":"Randall","year":"1997","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.07.001_b0495","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/1471-0528.12499","article-title":"Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: A national multicentre randomised trial","volume":"121","author":"\u00d8rbo","year":"2014","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.07.001_b0500","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0015-0282(03)01183-X","article-title":"Conservative treatment may be beneficial for young women with atypical endometrial hyperplasia or endometrial adenocarcinoma","volume":"80","author":"Jadoul","year":"2003","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.07.001_b0505","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/annonc\/mdq463","article-title":"Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women","volume":"22","author":"Minig","year":"2011","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.ejogrb.2023.07.001_b0510","first-page":"6799","article-title":"Cancer incidence in patients with atypical endometrial hyperplasia managed by primary hysterectomy or fertility-sparing treatment","volume":"35","author":"Gonthier","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0515","doi-asserted-by":"crossref","unstructured":"Nijkang NP, Anderson L, Markham R, Manconi F. Endometrial polyps: Pathogenesis, sequelae and treatment. SAGE Open Med. 2019;7.","DOI":"10.1177\/2050312119848247"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.07.001_b0520","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.gyobfe.2005.04.021","article-title":"Long-term results of hysteroscopic resection of endometrial polyps in 367 patients. Role of associated endometrial resection","volume":"33","author":"Polena","year":"2005","journal-title":"Gynecol Obstet Fertil"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0525","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jmig.2006.07.008","article-title":"Polypectomy in premenopausal women with abnormal uterine bleeding: Effectiveness of hysteroscopic removal","volume":"14","author":"Henriquez","year":"2007","journal-title":"J Minim Invasive Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.07.001_b0530","first-page":"886","article-title":"Treatment of endometrial polyps","volume":"96","author":"Tjarks","year":"2000","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0535","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ajog.2015.07.044","article-title":"The medical management of abnormal uterine bleeding in reproductive-aged women","volume":"214","author":"Bradley","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0540","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejogrb.2012.07.030","article-title":"Therapeutic management of uterine fibroid tumors: Updated French guidelines","volume":"165","author":"Marret","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"10.1016\/j.ejogrb.2023.07.001_b0545","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.0001-6349.2005.00690.x","article-title":"Short-term and long-term results of resectoscopic myomectomy with and without pretreatment with GnRH analogs in premenopausal women","volume":"84","author":"Campo","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.07.001_b0550","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-2002-32434","article-title":"A randomized controlled trial of levonorgestrel releasing IUD and thermal balloon ablation in the treatment of menorrhagia","volume":"124","author":"Soysal","year":"2002","journal-title":"Zentralbl Gynakol"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.07.001_b0555","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.fertnstert.2008.01.051","article-title":"Fibroids and infertility: an updated systematic review of the evidence","volume":"91","author":"Pritts","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0560","doi-asserted-by":"crossref","unstructured":"Metwally M, Raybould G, Cheong YC, Horne AW. Surgical treatment of fibroids for subfertility. Cochrane Database Syst Rev. 2020;1(1):CD003857.","DOI":"10.1002\/14651858.CD003857.pub4"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0565","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/09513590600604673","article-title":"Effects of the position of fibroids on fertility","volume":"22","author":"Casini","year":"2006","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0570","first-page":"2","article-title":"Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities","volume":"2015","author":"Bosteels","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0575","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0028-2243(91)90207-2","article-title":"Intranasal buserelin versus surgery in the treatment of uterine leiomyomata: long-term follow-up","volume":"38","author":"Fedele","year":"1991","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"10.1016\/j.ejogrb.2023.07.001_b0580","first-page":"CD003677","article-title":"Surgical approach to hysterectomy for benign gynaecological disease","volume":"2015","author":"Aarts","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.07.001_b0585","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/AOG.0b013e3181ed36b3","article-title":"Outcomes from leiomyoma therapies: Comparison with normal controls","volume":"116","author":"Spies","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.07.001_b0590","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.fertnstert.2009.05.070","article-title":"GnRH analogue treatment before hysteroscopic resection of submucous myomas: A prospective, randomized, multicenter study","volume":"94","author":"Muzii","year":"2010","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.07.001_b0595","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jmig.2017.11.011","article-title":"Intraoperative effect of preoperative gonadotropin-releasing hormone analogue administration in women undergoing cold loop hysteroscopic myomectomy: A randomized controlled trial","volume":"25","author":"Favilli","year":"2018","journal-title":"J Minim Invasive Gynecol"},{"issue":"9","key":"10.1016\/j.ejogrb.2023.07.001_b0600","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/humrep\/deq188","article-title":"The value of pre-operative treatment with GnRH analogues in women with submucous fibroids: A double-blind, placebo-controlled randomized trial","volume":"25","author":"Mavrelos","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0605","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejogrb.2015.06.018","article-title":"Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study","volume":"192","author":"Bizzarri","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.07.001_b0610","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0615","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejogrb.2016.11.003","article-title":"Real world data of 1473 patients treated with ulipristal acetate for uterine fibroids: Premya study results","volume":"208","author":"Fernandez","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0620","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejogrb.2020.05.043","article-title":"Efficacy and safety of vilaprisan in women with uterine fibroids: Data from the phase 2b randomized controlled trial ASTEROID 2","volume":"252","author":"Gemzell-Danielsson","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0625","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.steroids.2014.05.002","article-title":"Levonorgestrel-releasing intrauterine system use in premenopausal women with symptomatic uterine leiomyoma: A systematic review","volume":"86","author":"Jiang","year":"2014","journal-title":"Steroids"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.07.001_b0630","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1177\/030006051204000538","article-title":"Levonorgestrel-releasing intrauterine device is an efficacious contraceptive for women with leiomyoma","volume":"40","author":"Xie","year":"2012","journal-title":"J Int Med Res"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0635","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.contraception.2010.02.011","article-title":"Intrauterine device use among women with uterine fibroids: a systematic review","volume":"82","author":"Zapata","year":"2010","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0640","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijgo.2010.08.009","article-title":"A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia","volume":"112","author":"Sayed","year":"2011","journal-title":"Int J Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0645","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1701-2163(15)30338-8","article-title":"The management of uterine leiomyomas","volume":"37","author":"Vilos","year":"2015","journal-title":"J Obstet Gynaecol Can"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0650","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijgo.2016.04.020","article-title":"Randomized controlled trial of thermal balloon ablation versus vaginal hysterectomy for leiomyoma-induced heavy menstrual bleeding","volume":"135","author":"Jain","year":"2016","journal-title":"Int J Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.07.001_b0655","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/01.AOG.0000156298.74317.62","article-title":"Predictors of leiomyoma recurrence after myomectomy","volume":"105","author":"Hanafi","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0660","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.AOG.0000136079.62513.39","article-title":"Uterine myomas: An overview of development, clinical features, and management","volume":"104","author":"Wallach","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0665","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/AOG.0000000000003354","article-title":"Short-term health-related quality of life after hysterectomy compared with myomectomy for symptomatic leiomyomas","volume":"134","author":"Nicholson","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.07.001_b0670","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/oxfordjournals.humrep.a136176","article-title":"Recurrence of fibroids after myomectomy: A transvaginal ultrasonographic study","volume":"10","author":"Fedele","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0675","doi-asserted-by":"crossref","unstructured":"Fonseca MCM, Castro R, Machado M, Conte T, Girao MJBC. Uterine artery embolization and surgical methods for the treatment of symptomatic uterine leiomyomas: A systemic review and meta-analysis followed by indirect treatment comparison. Clin Ther. 2017;39(7):1438-1455.e2.","DOI":"10.1016\/j.clinthera.2017.05.346"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.07.001_b0680","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1914735","article-title":"Uterine-artery embolization or myomectomy for uterine fibroids","volume":"383","author":"Manyonda","year":"2020","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ejogrb.2023.07.001_b0685","article-title":"Uterine artery embolization for symptomatic uterine fibroids","volume":"2014","author":"Gupta","year":"2014","journal-title":"Cochrane Database Syst Rev [Internet]"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0690","doi-asserted-by":"crossref","first-page":"108700","DOI":"10.1016\/j.ejrad.2019.108700","article-title":"Magnetic resonance-high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: A systematic review and meta-analysis","volume":"120","author":"Verpalen","year":"2019","journal-title":"Eur J Radiol [Internet]"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0695","doi-asserted-by":"crossref","unstructured":"Laughlin-Tommaso S, Barnard EP, AbdElmagied AM, Vaughan LE, Weaver AL, Hesley GK, et al. FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery. Am J Obstet Gynecol. 2019;220(2):174.e1-174.e13.","DOI":"10.1016\/j.ajog.2018.10.032"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0700","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ijgo.13102","article-title":"Epidemiology and management of uterine fibroids","volume":"149","author":"Giuliani","year":"2020","journal-title":"Int J Gynecol Obstet"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.07.001_b0705","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1600-0412.2012.01361.x","article-title":"Efficacy of tranexamic acid in the treatment of idiopathic and non-functional heavy menstrual bleeding: A systematic review","volume":"91","author":"Naoulou","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0710","article-title":"Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding","volume":"2013","author":"Lethaby","year":"2013","journal-title":"Cochrane Database Syst Rev [Internet]"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0715","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.4103\/2141-9248.141955","article-title":"Pharmacological treatment of uterine fibroids","volume":"4","author":"Moroni","year":"2014","journal-title":"Ann Med Health Sci Res"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.07.001_b0720","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00404-017-4548-9","article-title":"High-intensity focused ultrasound (HIFU) treatment for uterine fibroids: a meta-analysis","volume":"296","author":"Ji","year":"2017","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.07.001_b0725","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00270-011-0228-5","article-title":"Uterine artery embolization versus myomectomy: Impact on quality of life - Results of the FUME (Fibroids of the uterus: Myomectomy versus embolization) trial","volume":"35","author":"Manyonda","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0730","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00270-007-9195-2","article-title":"Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy","volume":"31","author":"Mara","year":"2008","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0735","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/aogs.13698","article-title":"The impact of uterine artery embolization on ovarian reserve: A systematic review and meta-analysis","volume":"99","author":"El Shamy","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0740","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00404-017-4566-7","article-title":"Fertility after uterine artery embolization of fibroids: a systematic review","volume":"297","author":"Karlsen","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0745","doi-asserted-by":"crossref","unstructured":"de Bruijn AM, Ankum WM, Reekers JA, Birnie E, van der Kooij SM, Volkers NA, et al. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial. Am J Obstet Gynecol. 2016;215(6):745.e1-745.e12.","DOI":"10.1016\/j.ajog.2016.06.051"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0750","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1148\/radiol.2262011716","article-title":"Uterine fibroids: Uterine artery embolization versus abdominal hysterectomy for treatment - A prospective, randomized, and controlled clinical trial","volume":"226","author":"Pinto","year":"2003","journal-title":"Radiology"},{"issue":"10","key":"10.1016\/j.ejogrb.2023.07.001_b0755","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1007\/s00330-010-1829-0","article-title":"Uterine artery embolisation versus hysterectomy for leiomyomas: Primary and 2-year follow-up results of a randomised prospective clinical trial","volume":"20","author":"Ruuskanen","year":"2010","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.07.001_b0760","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/uog.7435","article-title":"Magnetic resonance-guided focused ultrasound (MRgFUS) compared with abdominal hysterectomy for treatment of uterine leiomyomas","volume":"34","author":"Taran","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.07.001_b0765","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.contraception.2015.05.015","article-title":"Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: A randomized clinical trial","volume":"92","author":"Shaaban","year":"2015","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.07.001_b0770","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S1074-3804(05)60158-2","article-title":"Insertion of mirena after endometrial resection in patients with adenomyosis","volume":"10","author":"Maia","year":"2003","journal-title":"J Am Assoc Gynecol Laparosc"},{"issue":"7\u20138","key":"10.1016\/j.ejogrb.2023.07.001_b0775","first-page":"285","article-title":"Comparison of combined transcervical resection of the endometrium and levonorgestrel-containing intrauterine system treatment versus levonorgestrel-containing intrauterine system treatment alone in women with adenomyosis: a prospective clinical trial","volume":"58","author":"Zheng","year":"2013","journal-title":"J Reprod Med"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.07.001_b0780","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1471-0528.1996.tb09807.x","article-title":"Treatment with a gonadotrophin releasing hormone agonist before endometrial resection: A multicentre, randomised controlled trial","volume":"103","author":"Vercellini","year":"1996","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.07.001_b0785","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.fertnstert.2008.07.1744","article-title":"Comparison of surgery alone and combined surgical-medical treatment in the management of symptomatic uterine adenomyoma","volume":"92","author":"Wang","year":"2009","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0790","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.fertnstert.2010.10.009","article-title":"Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis","volume":"95","author":"Ozdegirmenci","year":"2011","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.07.001_b0795","doi-asserted-by":"crossref","first-page":"150","DOI":"10.5152\/jtgga.2016.16073","article-title":"The effect of adenomyosis on the outcomes of laparoscopic hysterectomy","volume":"17","author":"Yavuzcan","year":"2016","journal-title":"J Turk Ger Gynecol Assoc"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0800","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/jog.12163","article-title":"Microwave endometrial ablation at a frequency of 2.45 GHz for menorrhagia: Analysis of treatment results at a single facility","volume":"40","author":"Nakayama","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0805","first-page":"100029","article-title":"The effect of transcervical endometrial resection on clinical symptoms related to intrinsic adenomyosis and junctional zone changes","volume":"3","author":"Rasmussen","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol X [Internet]"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0810","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/00016340500424314","article-title":"Transcervical endometrial resection: Long-term results of 390 procedures","volume":"85","author":"Engelsen","year":"2006","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.07.001_b0815","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1074-3804(05)60403-3","article-title":"Factors influencing long-term outcome of loop endometrial resection","volume":"9","author":"P\u00e9rez-Medina","year":"2002","journal-title":"J Am Assoc Gynecol Laparosc"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.07.001_b0820","first-page":"305","article-title":"Long-term results in the treatment of menorrhagia and hypermenorrhea with a thermal balloon endometrial ablation technique","volume":"6","author":"Mettler","year":"2002","journal-title":"JSLS J Soc Laparoendosc Surg Soc Laparoendosc Surg"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0825","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejogrb.2018.04.001","article-title":"Evaluation of NovaSure \u00ae global endometrial ablation in symptomatic adenomyosis: A longitudinal study with a 36 month follow-up","volume":"227","author":"Philip","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.07.001_b0830","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.fertnstert.2018.01.013","article-title":"Role of medical therapy in the management of uterine adenomyosis","volume":"109","author":"Vannuccini","year":"2018","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.07.001_b0835","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/aogs.13798","article-title":"The role of levonorgestrel intra-uterine system in the management of adenomyosis: A systematic review and meta-analysis of prospective studies","volume":"99","author":"Abbas","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.07.001_b0840","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.fertnstert.2017.07.021","article-title":"Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study","volume":"108","author":"Osuga","year":"2017","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0845","doi-asserted-by":"crossref","first-page":"101978","DOI":"10.1016\/j.jogoh.2020.101978","article-title":"Ulipristal acetate use in adenomyosis: A randomized controlled trial","volume":"50","author":"Capmas","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod [Internet]"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.07.001_b0850","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1600-0412.2012.01350.x","article-title":"Aromatase inhibitors or gonadotropin-releasing hormone agonists for the management of uterine adenomyosis: A randomized controlled trial","volume":"91","author":"Badawy","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0855","doi-asserted-by":"crossref","unstructured":"de Bruijn AM, Smink M, Lohle PNM, Huirne JAF, Twisk JWR, Wong C, et al. Uterine artery embolization for the treatment of adenomyosis: A systematic review and meta-analysis. J Vasc Interv Radiol. 2017;28(12):1629-1642.e1.","DOI":"10.1016\/j.jvir.2017.07.034"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0860","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/ajo.13304","article-title":"Long-term durability of uterine artery embolisation for treatment of symptomatic adenomyosis","volume":"61","author":"Ma","year":"2021","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0865","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jmig.2019.07.029","article-title":"Is high-intensity focused ultrasound effective for the treatment of adenomyosis? A systematic review and meta-analysis","volume":"27","author":"Marques","year":"2020","journal-title":"J Minim Invasive Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.07.001_b0870","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jmig.2010.10.004","article-title":"Pathologic characteristics of hysterectomy specimens in women undergoing hysterectomy after global endometrial ablation","volume":"18","author":"Carey","year":"2011","journal-title":"J Minim Invasive Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0875","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jmig.2014.10.006","article-title":"Effect of undiagnosed deep adenomyosis after failed NovaSure endometrial ablation","volume":"22","author":"Mengerink","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0880","doi-asserted-by":"crossref","unstructured":"Grimbizis GF, Mikos T, Tarlatzis B. Uterus-sparing operative treatment for adenomyosis. Fertil Steril. 2014;101(2):472-487.e8.","DOI":"10.1016\/j.fertnstert.2013.10.025"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0885","doi-asserted-by":"crossref","unstructured":"Mikos T, Lioupis M, Anthoulakis C, Grimbizis GF. The outcome of fertility-sparing and nonfertility-sparing surgery for the treatment of adenomyosis. A systematic review and meta-analysis. J Minim Invasive Gynecol. 2020;27(2):309-331.e3.","DOI":"10.1016\/j.jmig.2019.08.004"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.07.001_b0890","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jmig.2017.07.014","article-title":"Conservative surgery for adenomyosis and results: A systematic review","volume":"25","author":"Younes","year":"2018","journal-title":"J Minim Invasive Gynecol"},{"issue":"2\u201303","key":"10.1016\/j.ejogrb.2023.07.001_b0895","first-page":"157","article-title":"Current and future surgical and interventional management options for adenomyosis","volume":"38","author":"Chen","year":"2020","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0900","doi-asserted-by":"crossref","unstructured":"De Bruijn AM, Lohle PNM, Huirne JAF, De Vries J, Twisk M, Hehenkamp WJK, et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic adenomyosis: Protocol for the randomized QUESTA trial. JMIR Res Protoc [Internet]. 2018;7(3).","DOI":"10.2196\/resprot.8512"},{"key":"10.1016\/j.ejogrb.2023.07.001_b0905","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/1471-0528.14746","article-title":"A comparison of the cost\u2013utility of ultrasound-guided high-intensity focused ultrasound and hysterectomy for adenomyosis: a retrospective study","volume":"124","author":"Liu","year":"2017","journal-title":"BJOG Int J Obstet Gynaecol"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523002749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523002749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T06:01:40Z","timestamp":1759557700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211523002749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":181,"alternative-id":["S0301211523002749"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.07.001","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of women with abnormal uterine bleeding: Clinical practice guidelines of the French National College of Gynaecologists and Obstetricians (CNGOF)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}